Olmesartan

Independent reference data for Olmesartan (CAS 144689-24-7), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Physicochemical values on record

Documented uses on record

Angiotensin II Type 1 Receptor Blockers; Antihypertensive AgentsPreparation: H. Yanagisawa et al., European Patent Office patent 503785; eidem, United States of America patent 5616599 (1992, 1997 both to Sankyo).

Synonyms and trade names

Olmesartan; 144689-24-7; RNH-6270; omesartan; NSC-759810; 8W1IQP3U10; DTXSID2040571; CHEBI:48416; olmesartanum; olmesartanum medoxomilum; RefChem:55770; DTXCID0020571; Olmesartan Acid; 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid; CS-088; MFCD00914967

Regulatory listings held on file

GHS notification summary	33.3% (1 / 3)

GHS hazard classification

GHS notification summary	33.3% (1 / 3)
Reported hazard statements	H302 (66.7%), H312 (66.7%), H315 (33.3%), H319 (33.3%), H332 (66.7%), H335 (33.3%)

This chemical does not meet GHS hazard criteria for 33.3% (1 of 3) of reports.

H302 (66.7%): Harmful if swallowed [Warning Acute toxicity, oral]

What the public record says

Olmesartan · CAS 144689-24-7 · C24H26N6O3. UNII 8W1IQP3U10. Boiling Point: 800; Melting Point: 177.6; Melting Point: 175 - 180 °C.

Physical description and handling notes

Source: PubChem / Wikidata; the batch COA governs where values differ.